ENTX vs TECH · rev $181.0K vs P/E 65, rev $1.22B
Entera Bio Ltd (ENTX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ENTX revenue for 2024-12-31 was $181.0K. Net income was -$9.5M. ENTX currently screens at market cap $58.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ENTX currently screens at market cap $58.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ENTX and TECH stock pages for the full models.
Not investment advice.